Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    82.57
    -0.24 (-0.29%)
     
  • GOLD FUTURES

    2,342.70
    +4.30 (+0.18%)
     
  • DOW

    38,008.58
    -452.34 (-1.18%)
     
  • Bitcoin GBP

    51,480.01
    -238.59 (-0.46%)
     
  • CMC Crypto 200

    1,386.21
    +3.64 (+0.26%)
     
  • NASDAQ Composite

    15,544.46
    -168.29 (-1.07%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

AstraZeneca wins approval for lung cancer pill in China

LONDON, March 27 (Reuters) - AstraZeneca (NYSE: AZN - news) said on Monday it had won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.

Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and other parts of east Asia. (Reporting by Ben Hirschler; editing by Kate Holton)